News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Valneva Se ADR
(NQ:
VALN
)
7.340
-0.240 (-3.16%)
Streaming Delayed Price
Updated: 3:56 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Valneva Se ADR
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
Analyst Scoreboard: 8 Ratings For Valneva
August 14, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
July 22, 2024
Via
Benzinga
The Analyst Landscape: 6 Takes On Valneva
June 24, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
May 31, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Valneva
May 08, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
VALN stock results show that Valneva missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
July 29, 2024
Healthcare innovations are big business. That said, biotech stocks under $10 may offer a higher ceiling thanks to their low price.
Via
InvestorPlace
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026
July 18, 2024
Pfizer and Valneva announced the completion of the primary vaccination series in the Phase 3 VALOR trial for their Lyme disease vaccine, VLA15. Participants will be monitored until the end of the 2025...
Via
Benzinga
Valneva Seeks Expanded Use For Its Chikungunya Vaccine In Adolescents With Encouraging Phase 3 Data
May 13, 2024
Valneva released positive Phase 3 data for its single-shot chikungunya virus vaccine in adolescents. The vaccine is also expected to be approved for use in Brazil.
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
VALN stock results show that Valneva missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
What Analysts Are Saying About Valneva Stock
March 22, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses Revenue for Q4 2023
March 20, 2024
VALN stock results show that Valneva missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Expert Ratings for Valneva
December 04, 2023
Via
Benzinga
Analyst Ratings for Valneva
November 10, 2023
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
March 08, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novavax’s dispute resolution and upcoming earnings call
February 23, 2024
Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
Analyst Ratings for Valneva
September 07, 2023
Via
Benzinga
Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline
February 05, 2024
Valneva sells FDA Priority Review Voucher for $103 million after FDA approval of Ixchiq, the world's first licensed chikungunya vaccine. Proceeds to boost R&D projects.
Via
Benzinga
Exposures
Product Safety
McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday
February 05, 2024
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Valneva Says Single Chikungunya Vaccine Shows Long-Lasting Antibody Response In Younger, Older Adults
December 04, 2023
Valneva SE (NASDAQ: VALN) reported antibody persistence data 24 months after vaccination with a single dose of its chikungunya vaccine IXCHIQ, further supporting the anticipated long-term durability of...
Via
Benzinga
FDA Approves World's First Mosquito-Borne Chikungunya Vaccine
November 10, 2023
The FDA approved Valneva SE's (NASDAQ: VALN) Chikungunya single-dose vaccine in individuals
Via
Benzinga
Exposures
Product Safety
Pfizer, Valneva's Tick-Borne Infection Shot: Companies Say 'Positive' Result For Lyme Disease Vaccine Candidate Booster
September 07, 2023
Valneva SE (NASDAQ: VALN) and Pfizer Inc (NYSE: PFE) released pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate,
Via
Benzinga
7 Unmatched Stocks: The Untapped Goldmines to Buy Now.
August 24, 2023
Although these ideas for stocks with potential present high risk, they may also offer robust, even game-changing returns.
Via
InvestorPlace
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 14, 2023
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 14, 2023
Via
Benzinga
AMC Entertainment, Nikola, Cleveland-Cliffs And Other Big Stocks Moving Lower In Monday's Pre-Market Session
August 14, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Top 5 Health Care Stocks That May Crash This Month
June 22, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.